December 14, 2017

AmerisourceBergen Foundation Launches Municipal Support Program to Help Combat Opioid Abuse

Foundation to distribute drug deactivation resources to communities nationwide to promote the safe disposal of opioids 

VALLEY FORGE, Pa. – The AmerisourceBergen Foundation today announced the launch of a municipal support program that aims to promote the safe disposal of opioids by providing communities nationwide with resources to deactivate expired or unused prescription medications.

As part of the program, the AmerisourceBergen Foundation – a not-for-profit charitable organization focused on supporting health-related causes that enrich the global community and the philanthropic arm of AmerisourceBergen Corporation – will distribute drug deactivation resources to municipalities that are actively working to prevent opioid abuse and misuse. The disposable resources use a new technology, which – when combined with water – effectively deactivate opioids, rendering them ineffective for misuse and providing a safe solution for site-of-use disposal.

“The epidemic of opioid abuse demands action, attention and a collaborative approach. The safe disposal of unused prescription medications is a critical component in combating the issue, as it reduces the risk for misuse, abuse and diversion,” said Gina Clark, President of the AmerisourceBergen Foundation who is also Executive Vice President and Chief Communications & Administration Officer at AmerisourceBergen. “At AmerisourceBergen and the AmerisourceBergen Foundation, we are united in our responsibility to create healthier futures. Through this program, we will provide communities with the resources needed to deactivate prescription medications in a safe and effective manner, and help advance their efforts to prevent opioid abuse.”

As a global healthcare solutions leader, AmerisourceBergen plays a critical role in the pharmaceutical supply chain, working as a link between manufacturers and healthcare providers to help ensure patients have access to the medications they need, when they need them.

In order to support the Foundation’s new program, AmerisourceBergen will leverage its network of distribution centers to provide communities across the country with access to the drug deactivation resources.

Municipal entities that are interested in applying for the drug deactivation resources or learning more about the program can visit the AmerisourceBergen Foundation website at:


About the AmerisourceBergen Foundation
Established in 2014, the AmerisourceBergen Foundation focuses on health and wellbeing initiatives that improve patient outcomes including pharmaceutical accessibility programs, pharmaceutical adherence programs and health improvement research. The Foundation aims to enhance healthcare delivery and improve access. The AmerisourceBergen Foundation is a separate not-for-profit charitable organization distinct from AmerisourceBergen Corporation. For more information on the AmerisourceBergen Foundation, visit:

About AmerisourceBergen
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust us as their partner in the pharmaceutical supply chain. Global manufacturers depend on us for services that drive commercial success for their products. Through our daily work—and powered by our 20,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #11 on the Fortune 500, with more than $150 billion in annual revenue. The company is headquartered in Valley Forge, Pa. and has a presence in 50+ countries. Learn more at